Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Monday, December 01, 2014 8:13:32 AM
I'm here to tell the truth to those that don't take the time to get the facts straight.
Musclepharm is a company with high executive compensation. It is a company that spends a lot of money on athletic endorsements too.
Naturally, you would think that such a company was highly profitable...problem is that Musclepharm isn't profitable ex one time items. Also, Musclepharm doesn't have any manufacturing of it's own.
So, how does this company pay for all that? It pays through issuing stocks....OUCH! yeah, I know...not very good!
SEC, institutional investors, creditors, employees and industry experts....everybody is taking notice of this.
Okay, the management build up a semi-strong brand in short time and we are at close to $200 million in revenue....but when will employees be treated well?, when can creditors trust that loans can be paid back? and when can investors trust that the stock won't be excessively diluted?
Really, when will Musclepharm act like a regular company?
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM